NovaBay Pharmaceuticals Announces Laboratory Results Confirm Avenova Kills SARS-CoV-2 (COVID-19 Virus)

Nachrichtenquelle: Business Wire (engl.)
13.07.2020, 12:50  |  211   |   |   

NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) announces testing results from an independent third-party laboratory confirming that Avenova, NovaBay’s proprietary formulation of pure hypochlorous acid, kills SARS-CoV-2. Test results will be submitted to the Environmental Protection Agency (EPA) for the EPA’s approved list of disinfectants for use against SARS-CoV-2.

“Since Avenova’s inception, we have known it to be a powerful antimicrobial spray solution, effective against all types of pathogens, including a wide variety of viruses, bacteria, and fungi. Now we have results from a highly reputable independent laboratory confirming Avenova kills the coronavirus that causes COVID-19,” said Justin Hall, NovaBay CEO.

The study was designed to determine Avenova’s effectiveness against the SARS-CoV-2 on a hard surface. Testing was performed with the USA-WA1/2020 strain of SARS-CoV-2 at room temperature (20 degrees Celsius [68 degrees Fahrenheit] +/- 1 degree) in a 5.0% serum in viral inoculum on a glass Petri dish. Avenova (active ingredient of 0.01% hypochlorous acid in saline solution) was sprayed on the surface from a distance of six to eight inches until the surface was thoroughly wet. Results at 60 seconds prove Avenova’s ability to fully inactivate the virus.

“Most COVID-19 transmission is likely due to person-to-person contact as respiratory droplets containing the virus spread through the air by speaking or even breathing, and reach others in close proximity. These large droplets transmit the virus by entering the body typically through the eyes, nose or mouth,” explained Mr. Hall.

“Avenova, formulated with our pure, FDA-cleared hypochlorous acid, is completely non-toxic and is safe for use on all skin surfaces, including delicate facial skin around eyes, nose and mouth. As a cautionary note, I would like to warn consumers that not all hypochlorous acid products are alike. Some are not designed for use on skin the way Avenova is, and others are not as pure and should not be used on skin on a daily basis. Additionally, some hypochlorous acid products are not of a high pharmaceutical grade like ours and may not maintain a sufficiently high concentration of hypochlorous acid to kill SARS-CoV-2.”

Seite 1 von 3

Diesen Artikel teilen

0 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren



Meistgelesene Nachrichten des Autors